US FDA approves Celcuity's breast cancer drug - Reuters
US FDA approves Celcuity's breast cancer drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOVlQwdGFBOVJZNDBha3U3SkdCaF9hOHE4QmxPR2YzVXdIT2ZBM3FNbG8ycHJMSVVVNHZhOHdoRU1iekp0QnowME0zMkhWdGlkdzItMF80eVNRVklWOXFUeVI3QjF4ckRoS3BFTHdLaFo3UkxNZElGQjBzNVJCajJwZHZCQzE2N2JhTDlZM0RTX2ZOXzZHNjVDU0N1TGMzQzNPaHo4enFfd191eVNuVEFMaWprZnRXQ0k?oc=5" target="_blank">US FDA approves Celcuity's breast cancer drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMUS FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
August 28, 2026 at 10:16 PMUS FDA approves Roivant-Priovant's skin and muscle disease drug - Reuters
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
August 27, 2026 at 10:42 PMBristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AM